Vote Brendan J, Russell Matthew K, Joondeph Brian C
Department of Ophthalmology, University of Auckland, Auckland, New Zealand.
Retina. 2004 Oct;24(5):736-8. doi: 10.1097/00006982-200410000-00008.
To evaluate the efficacy of trypan blue dye for the staining and removal of the internal limiting membrane, epiretinal membranes, and the posterior hyaloid during pars plana vitrectomy.
The authors retrospectively reviewed a consecutive series of 26 eyes of 26 patients in whom trypan blue 0.15% dye was used to stain intraocular tissues during vitrectomy surgery.
The cases reviewed included the following diagnoses: epiretinal membrane (13), macular hole (9), proliferative vitreoretinopathy (2), chronic pseudophakic cystoid macular edema (1), and chronic diabetic macular edema (1). The application of trypan blue resulted in a useful and consistent bluish staining, facilitating the identification, delineation, and removal of the epiretinal membrane, internal limiting membrane, or posterior hyaloid in all patients. Six months after the surgery, visual acuity was better or the same in 21 of the 26 patients. There were no clinical signs of retinal toxicity in any patients.
Trypan blue staining of the internal limiting membrane, epiretinal membranes, and the posterior hyaloid is a useful adjunct in vitreoretinal surgery and improves the efficiency and safety of membrane identification and removal.
评估台盼蓝染料在玻璃体切割术中对视网膜内界膜、视网膜前膜及玻璃体后皮质进行染色和清除的效果。
作者回顾性分析了连续26例患者的26只眼,这些患者在玻璃体切除术中使用0.15%的台盼蓝染料对眼内组织进行染色。
回顾的病例包括以下诊断:视网膜前膜(13例)、黄斑裂孔(9例)、增殖性玻璃体视网膜病变(2例)、慢性人工晶状体眼黄斑囊样水肿(1例)和慢性糖尿病性黄斑水肿(1例)。台盼蓝的应用产生了有用且一致的蓝色染色,有助于所有患者识别、界定和清除视网膜前膜、视网膜内界膜或玻璃体后皮质。术后6个月,26例患者中有21例视力改善或不变。所有患者均无视网膜毒性的临床体征。
视网膜内界膜、视网膜前膜及玻璃体后皮质的台盼蓝染色是玻璃体视网膜手术中的一种有用辅助手段,可提高膜识别和清除的效率及安全性。